Here are relevant reports on : ai-diagnostic-imaging-market

• AI Agents in Healthcare Market by Function (Scheduling, Billing, Diagnostic, Treatment, RPM, Telehealth), Offering (Multi-Agent), Architecture (Contextual, Conversational), End User (Hospital, ACS, Imaging Center), Trends, Growth - Global Forecast to 2030

  The global AI Agents in Healthcare market, valued at US$0.76 billion in 2024, stood at US$1.11 billion in 2025 and is projected to advance at a resilient CAGR of 44.1% from 2025 to 2030, culminating in a forecasted valuation of US$6.92 billion by the end of the period. Advances in generative AI, natural language processing, and seamless integration with electronic health records (EHRs) are enabling AI agents to handle a range of tasks, from patient engagement and appointment scheduling to clinical decision support and documentation assistance.

  • Published: January 2026
  • Price: $ 4950
  • TOC Available:

• Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecast to 2028

  The global breast imaging market, valued at US$4.1 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.5% from 2023 to 2028, culminating in a forecasted valuation of US$6.6 billion by the end of the period.The increasing number of research grants, rising focus on contrast-based diagnostic solutions, and rising awareness in developing economies are expected to drive the market during the forecast period.

  • Published: June 2023
  • Price: $ 4950
  • TOC Available:

• Medical Imaging Workstations Market by Component (CPU, Hardware, Image Software), Modality (CT, MRI, Mammography), Application (Clinical Review, Diagnostic Imaging, 3D Imaging), Specialty, and Region - Global Forecasts to 2023

  The medical imaging workstations market is projected to reach USD 1,377 million by 2023, growing at a CAGR of 8.9%. Factors such as the rising global burden of target diseases, increased product commercialization, rising public-private investments to support product development, evolving user preference for digital platforms, and the establishment of new medical facilities are driving the growth of the global medical imaging workstations market. General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Carestream Health (US), Hologic (US), Carl Zeiss Meditec AG (Germany), Accuray Incorporated (US), Capsa Healthcare (US), Ampronix (US), Medicor Imaging (US), NGI Group (France), Alma IT Systems (Spain), and Pie Medical Imaging (Netherlands) are some of the major players operating in the global medical imaging workstations market.

  • Published: January 2019
  • Price: $ 4950
  • TOC Available:

• Dental Imaging Market by Product (Extraoral Imaging (CBCT, Panoramic), Intraoral Imaging (X-ray, Intraoral Camera, IOL Scanner)), Application (Endodontics, Implantology), & End User (Dental Hospitals, Dental Diagnostic Centers) - Global Forecast to 2030

  The global dental imaging market, valued at US$3.08 billion in 2024, stood at US$3.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.69 billion by the end of the period. The prominent players in the dental imaging market include Envista Holdings Corporation (US), Planmeca Oy (Finland), ACTEON (UK), DENTSPLY SIRONA Inc. (US), Carestream Dental LLC (US), VATECH (South Korea), Owandy Radiology, Inc. (France), DÜRR DENTAL AG (Germany), Midmark Corporation (US), Genoray Co., Ltd. (South Korea), Asahi Roentgen Co., Ltd. (Japan), 3Shape (Denmark), PreXion, Inc. (US), Ningbo Runyes Medical Instrument Co. Ltd.(China), Cefla Medical Equipment (Italy), Apteryx Imaging (Canada), Yoshida Dental Mfg. Co., Ltd. (Japan), Align Technology Inc. (US), J. MORITA CORP (Japan), and FONA Srl (Italy).

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028

  The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.

  • Published: April 2024
  • Price: $ 4950
  • TOC Available:

• Teleradiology Market by Product & Service (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers & Laboratories) & Region - Global Forecast to 2026

  The global teleradiology market growth is primed to transition from $7.3 billion in 2021 to $14.8 billion by 2026, showcasing a strong CAGR of 15.3%. Key growth drivers include the rising elderly population, increased imaging procedures, a shortage of radiologists, and technological advancements like cloud-based solutions and artificial intelligence (AI).

  • Published: January 2022
  • Price: $ 4950
  • TOC Available:

• Vascular Imaging Market by Technology (MRI, Ultrasound, CT, Hybrid, OCT), Application (Atherosclerosis, DVT, Vasculitis, Aneurysmal Disorders, AV Malformations, Tumours, Others), End User (Hospitals, Diagnostic Imaging Centers) - Global Forecast to 2030

  The global vascular imaging market, valued at US$3.03 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2030, culminating in a forecasted valuation of US$4.67 billion by the end of the period. The growth of the vascular imaging market is driven by the rising prevalence of cardiovascular diseases, including atherosclerosis, peripheral artery disease, and stroke, which demand early diagnosis and monitoring.

  • Published: November 2025
  • Price: $ 4950
  • TOC Available:

• Medical Image Management Market by Product (PACS (Departmental, Radiology, Mammography, Cardiology, Enterprise), VNA (On-premise, Hybrid, Cloud), AICA, Universal Viewer), End User (Hospitals, Diagnostic Imaging Centers, ASC, CRO) - Global Forecast to 2023

  The medical image management market is projected to reach USD 4.40 billion in 2023, growing at a CAGR of 7.7% . Prominent players in this market include McKesson Corporation (US), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Merge Healthcare Inc. (US), Agfa-Gevaert Group (Belgium), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Carestream Health, Inc. (US), BridgeHead Software (UK), Novarad Corporation (US), Mach7 Technologies Ltd. (US), and INFINITT Healthcare Co., Ltd.(South Korea).

  • Published: August 2018
  • Price: $ 4950
  • TOC Available:

• European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025

  European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.

  • Published: May 2020
  • Price: $ 4950
  • TOC Available:

• Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024

  The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).

  • Published: December 2019
  • Price: $ 4950
  • TOC Available:

• NEXT
• LAST

Records 1 to 10 of 50